{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:02:19Z","timestamp":1790722939008,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1673-5374.264446","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T10:56:31Z","timestamp":1568631391000},"page":"36","source":"Crossref","is-referenced-by-count":53,"title":["Stem cell therapy for Parkinson\u2019s disease: safety and modeling"],"prefix":"10.4103","volume":"15","author":[{"given":"Theo","family":"Stoddard-Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ReneeReijo","family":"Pera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.264446-1","doi-asserted-by":"crossref","unstructured":"Byers B, Lee HL, Reijo Pera R (2012) Modeling Parkinson\u2019s disease using induced pluripotent stem cells. Curr Neurol Neurosci Rep 12:237-242.","DOI":"10.1007\/s11910-012-0270-y"},{"key":"key-10.4103\/1673-5374.264446-2","doi-asserted-by":"crossref","unstructured":"Cooper O, Astradsson A, Hallett P, Robertson H, Mendez I, Isacson O (2009) Lack of functional relevance of isolated cell damage in transplants of Parkinson\u2019s disease patients. J Neurol 256 Suppl 3:310-316.","DOI":"10.1007\/s00415-009-5242-z"},{"key":"key-10.4103\/1673-5374.264446-3","doi-asserted-by":"crossref","unstructured":"Cooper O, Parmar M, Isacson O (2012) Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy. Prog Brain Res 200:265-276.","DOI":"10.1016\/B978-0-444-59575-1.00012-0"},{"key":"key-10.4103\/1673-5374.264446-4","doi-asserted-by":"crossref","unstructured":"Cyranoski D (2017) Trials of embryonic stem cells to launch in China. Nature 546:15-16.","DOI":"10.1038\/546015a"},{"key":"key-10.4103\/1673-5374.264446-5","doi-asserted-by":"crossref","unstructured":"Doi D, Samata B, Katsukawa M, Kikuchi T, Morizane A, Ono Y, Sekiguchi K, Nakagawa M, Parmar M, Takahashi J (2014) Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports 2:337-350.","DOI":"10.1016\/j.stemcr.2014.01.013"},{"key":"key-10.4103\/1673-5374.264446-6","doi-asserted-by":"crossref","unstructured":"Fasano CA, Chambers SM, Lee G, Tomishima MJ, Studer L (2010) Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell 6:336-347.","DOI":"10.1016\/j.stem.2010.03.001"},{"key":"key-10.4103\/1673-5374.264446-7","doi-asserted-by":"crossref","unstructured":"Hallett PJ, Deleidi M, Astradsson A, Smith GA, Cooper O, Osborn TM, Sundberg M, Moore MA, Perez-Torres E, Brownell AL, Schumacher JM, Spealman RD, Isacson O (2015) Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson\u2019s disease. Cell Stem Cell 16:269-274.","DOI":"10.1016\/j.stem.2015.01.018"},{"key":"key-10.4103\/1673-5374.264446-8","doi-asserted-by":"crossref","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184.","DOI":"10.1136\/jnnp.55.3.181"},{"key":"key-10.4103\/1673-5374.264446-9","doi-asserted-by":"crossref","unstructured":"Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E, Agundez JA (2016) Advances in understanding genomic markers and pharmacogenetics of Parkinson\u2019s disease. Expert Opin Drug Metab Toxicol 12:433-448.","DOI":"10.1517\/17425255.2016.1158250"},{"key":"key-10.4103\/1673-5374.264446-10","doi-asserted-by":"crossref","unstructured":"Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Schindzielorz A, Okochi M, Leimer U, van Der Putten H, Probst A, Kremmer E, Kretzschmar HA, Haass C (2000) Subcellular localization of wild-type and Parkinson\u2019s disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci 20:6365-6373.","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000"},{"key":"key-10.4103\/1673-5374.264446-11","doi-asserted-by":"crossref","unstructured":"Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, Mizuma H, Takara S, Takahashi R, Inoue H, Morita S, Yamamoto M, Okita K, Nakagawa M, Parmar M, Takahashi J (2017) Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model. Nature 548:592-596.","DOI":"10.1038\/nature23664"},{"key":"key-10.4103\/1673-5374.264446-12","doi-asserted-by":"crossref","unstructured":"Kim HJ, Jeon B (2016) How close are we to individualized medicine for Parkinson\u2019s disease? Expert Rev Neurother 16:815-830.","DOI":"10.1080\/14737175.2016.1182021"},{"key":"key-10.4103\/1673-5374.264446-13","doi-asserted-by":"crossref","unstructured":"Kirkeby A, Grealish S, Wolf DA, Nelander J, Wood J, Lundblad M, Lindvall O, Parmar M (2012) Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep 1:703-714.","DOI":"10.1016\/j.celrep.2012.04.009"},{"key":"key-10.4103\/1673-5374.264446-14","doi-asserted-by":"crossref","unstructured":"Langston JW (2006) The Parkinson\u2019s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59:591-596.","DOI":"10.1002\/ana.20834"},{"key":"key-10.4103\/1673-5374.264446-15","doi-asserted-by":"crossref","unstructured":"Lemon RN (2008) Descending pathways in motor control. Annu Rev Neurosci 31:195-218.","DOI":"10.1146\/annurev.neuro.31.060407.125547"},{"key":"key-10.4103\/1673-5374.264446-16","doi-asserted-by":"crossref","unstructured":"Liu AK, Chang RC, Pearce RK, Gentleman SM (2015) Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease. Acta Neuropathol 129:527-540.","DOI":"10.1007\/s00401-015-1392-5"},{"key":"key-10.4103\/1673-5374.264446-17","doi-asserted-by":"crossref","unstructured":"Maherali N, Hochedlinger K (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3:595-605.","DOI":"10.1016\/j.stem.2008.11.008"},{"key":"key-10.4103\/1673-5374.264446-18","doi-asserted-by":"crossref","unstructured":"Morizane A, Kikuchi T, Hayashi T, Mizuma H, Takara S, Doi H, Mawatari A, Glasser MF, Shiina T, Ishigaki H, Itoh Y, Okita K, Yamasaki E, Doi D, Onoe H, Ogasawara K, Yamanaka S, Takahashi J (2017) MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nat Commun 8:385.","DOI":"10.1038\/s41467-017-00926-5"},{"key":"key-10.4103\/1673-5374.264446-19","doi-asserted-by":"crossref","unstructured":"Nashun B, Hill PW, Hajkova P (2015) Reprogramming of cell fate: epigenetic memory and the erasure of memories past. EMBO J 34:1296-1308.","DOI":"10.15252\/embj.201490649"},{"key":"key-10.4103\/1673-5374.264446-20","doi-asserted-by":"crossref","unstructured":"Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P, Kee K, Sch\u00fcle B, Dolmetsch RE, Langston W, Palmer TD, Pera RR (2011) LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8:267-280.","DOI":"10.1016\/j.stem.2011.01.013"},{"key":"key-10.4103\/1673-5374.264446-21","doi-asserted-by":"crossref","unstructured":"OkitaOkita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8:409-412.","DOI":"10.1038\/nmeth.1591"},{"key":"key-10.4103\/1673-5374.264446-22","doi-asserted-by":"crossref","unstructured":"Peng J, Liu Q, Rao M, Zeng X (2014) Survival and engraftment of dopaminergic neurons manufactured by a Good Manufacturing Practice-compatible process. Cytotherapy 16:1305-1312.","DOI":"10.1016\/j.jcyt.2014.06.002"},{"key":"key-10.4103\/1673-5374.264446-23","doi-asserted-by":"crossref","unstructured":"Phetfong J, Supokawej A, Wattanapanitch M, Kheolamai P, U-Pratya Y, Issaragrisil S (2016) Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage. Cell Tissue Res 365:101-112.","DOI":"10.1007\/s00441-016-2369-y"},{"key":"key-10.4103\/1673-5374.264446-24","doi-asserted-by":"crossref","unstructured":"Playne R, Connor B (2017) Understanding Parkinson\u2019s disease through the use of cell reprogramming. Stem Cell Rev 13:151-169.","DOI":"10.1007\/s12015-017-9717-5"},{"key":"key-10.4103\/1673-5374.264446-25","doi-asserted-by":"crossref","unstructured":"Reinhardt P, Schmid B, Burbulla LF, Sch\u00f6ndorf DC, Wagner L, Glatza M, H\u00f6ing S, Hargus G, Heck SA, Dhingra A, Wu G, M\u00fcller S, Brockmann K, Kluba T, Maisel M, Kr\u00fcger R, Berg D, Tsytsyura Y, Thiel CS, Psathaki OE, et al. (2013) Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12:354-367.","DOI":"10.1016\/j.stem.2013.01.008"},{"key":"key-10.4103\/1673-5374.264446-26","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-G\u00f3mez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, Musachio JL, Chin FT, Toyama H, Seidel J, Green MV, Thanos PK, Ichise M, Pike VW, Innis RB, McKay RD (2007) Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25:918-928.","DOI":"10.1634\/stemcells.2006-0386"},{"key":"key-10.4103\/1673-5374.264446-27","doi-asserted-by":"crossref","unstructured":"Sanders LH, Lagani\u00e8re J, Cooper O, Mak SK, Vu BJ, Huang YA, Paschon DE, Vangipuram M, Sundararajan R, Urnov FD, Langston JW, Gregory PD, Zhang HS, Greenamyre JT, Isacson O, Sch\u00fcle B (2014) LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson\u2019s disease patients: reversal by gene correction. Neurobiol Dis 62:381-386.","DOI":"10.1016\/j.nbd.2013.10.013"},{"key":"key-10.4103\/1673-5374.264446-28","doi-asserted-by":"crossref","unstructured":"Sch\u00f6ndorf DC, Aureli M, McAllister FE, Hindley CJ, Mayer F, Schmid B, Sardi SP, Valsecchi M, Hoffmann S, Schwarz LK, Hedrich U8, Berg D, Shihabuddin LS, Hu J, Pruszak J, Gygi SP, Sonnino S, Gasser T, Deleidi M (2014) iPSC-derived neurons from GBA1-associated Parkinson\u2019s disease patients show autophagic defects and impaired calcium homeostasis. Nat Commun 5:4028.","DOI":"10.1038\/ncomms5028"},{"key":"key-10.4103\/1673-5374.264446-29","doi-asserted-by":"crossref","unstructured":"Soldner F, Lagani\u00e8re J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, Khurana V, Golbe LI, Myers RH, Lindquist S, Zhang L, Guschin D, Fong LK, Vu BJ, Meng X, Urnov FD, Rebar EJ, Gregory PD, Zhang HS, Jaenisch R (2011) Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146:318-331.","DOI":"10.1016\/j.cell.2011.06.019"},{"key":"key-10.4103\/1673-5374.264446-30","doi-asserted-by":"crossref","unstructured":"Spits C, Mateizel I, Geens M, Mertzanidou A, Staessen C, Vandeskelde Y, Van der Elst J, Liebaers I, Sermon K (2008) Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol 26:1361-1363.","DOI":"10.1038\/nbt.1510"},{"key":"key-10.4103\/1673-5374.264446-31","doi-asserted-by":"crossref","unstructured":"Takahashi J (2019) Preparing for first human trial of iPSC-derived cells for Parkinson\u2019s disease: an interview with Jun Takahashi. Regen Med 14:93-95.","DOI":"10.2217\/rme-2018-0158"},{"key":"key-10.4103\/1673-5374.264446-32","doi-asserted-by":"crossref","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.","DOI":"10.1016\/j.cell.2006.07.024"},{"key":"key-10.4103\/1673-5374.264446-33","unstructured":"Takahashi N, Sawamoto, N Kyoto (2018) Trial to Evaluate the Safety and Efficacy of iPSC-derived dopaminergic progenitors in the treatment of Parkinson\u2019s Disease. UMIN, Japan."},{"key":"key-10.4103\/1673-5374.264446-34","doi-asserted-by":"crossref","unstructured":"Wakabayashi K, Takahashi H (1997) Neuropathology of autonomic nervous system in Parkinson\u2019s disease. Eur Neurol 38 Suppl 2:2-7.","DOI":"10.1159\/000113469"},{"key":"key-10.4103\/1673-5374.264446-35","doi-asserted-by":"crossref","unstructured":"Wang YK, Zhu WW, Wu MH, Wu YH, Liu ZX, Liang LM, Sheng C, Hao J, Wang L, Li W, Zhou Q, Hu BY (2018) Human clinical-grade parthenogenetic ESC-derived dopaminergic neurons recover locomotive defects of nonhuman primate models of Parkinson\u2019s disease.Stem Cell Reports 11:171-182.","DOI":"10.1016\/j.stemcr.2018.05.010"},{"key":"key-10.4103\/1673-5374.264446-36","doi-asserted-by":"crossref","unstructured":"Ye W, Shimamura K, Rubenstein JL, Hynes MA, Rosenthal A (1998) FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93:755-766.","DOI":"10.1016\/S0092-8674(00)81437-3"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:40:25Z","timestamp":1786732825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.264446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["264446"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.264446","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}